Seer, Inc. Class A SEER 深 沪
等待开盘 06-30 09:30:00 美东时间
1.66
0.000
0.00%
华盛通- 最 高1.70
- 今 开1.68
- 成交量 21.82万股
- 最 低 1.66
- 昨 收 1.66
- 总市值 9126.94万
- 52周最高 2.41
- 市盈率 静 --
- 换手率 0.40%
- 52周最低 1.65
- 委 比 70.84%
- 总股本 5498.16万
- 历史最高 86.55
- 量 比 1.18
- 振 幅 2.41%
- 历史最低 1.455
- 每 手 1
- 风险率 0.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Radoff-JEC group urges Seer holders to back dissident slate in push for board change, $2.5 tender offer for 20 million shares
Radoff-JEC group urges Seer holders to back dissident slate in push for board change, $2.5 tender offer for 20 million shares Activist Radoff-JEC Group, holding about 7.7% of Seer, urged stockholders to back its three director nominees in a proxy fight. Group told investors not to vote for Omid Faro
06-24 20:45
Seer Board Pushes Back Against Activist Investor Campaign
Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") today issued a letter to stockholders containing important information for shareholders to consider in connection with the Company's upcoming Annual Meeting of Stockholders (the "Annual Meeting") to be held on July 28, 2026. Stockholders as of May 2...
06-15 19:12
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
Seer, Inc. urges shareholders to vote "FOR" its seven highly qualified director nominees on the BLUE proxy card at the upcoming Annual Meeting on July 28, 2026. The company highlights its leadership in deep, unbiased proteomics, scientific advancements, financial discipline, and a robust innovation pipeline. Seer opposes activist stockholders Bradley Radoff and Michael Torok, who have submitted unqualified nominations and proposals to acquire the...
06-15 11:00
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
Seer, Inc. has filed definitive proxy materials for its 2026 Annual Meeting of Stockholders, urging shareholders to vote for its seven highly qualified director nominees on the BLUE proxy card. The company highlights its clear strategy to build the market for deep, unbiased proteomics, disciplined financial management, and the strong qualifications of its Board of Directors. Seer strongly opposes Bradley Radoff and Michael Torok’s proxy fight, ar...
06-03 22:00
Seer Files ITC Complaint Against Nanomics
Seer, Inc. has filed a complaint with the U.S. International Trade Commission (ITC) against Nanomics Biotechnology Co., Ltd., alleging infringement of five of Seer's patents related to nanoparticle protein enrichment technology. Brigham and Women's Hospital has joined the complaint. Seer seeks an exclusion order to bar the importation of Nanomics' Proteonano kits and workstations into the U.S. Omid Farokhzad, CEO of Seer, emphasized the importanc...
05-29 11:00
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Seer, Inc. will showcase its Proteograph Product Suite at the 2026 ASMS conference, highlighting advancements in AI-driven proteomics for multi-cancer screening and scalable data processing. The company will present findings from a 20,000-sample collaboration with Korea University, demonstrating how deep plasma proteomics can enhance early cancer detection. Additionally, Seer will introduce Radiant DIA and Fulcrum Pipeline, tools designed to acce...
05-26 20:05
Full Transcript: Zoom Communications Q1 2027 Earnings Call
On Thursday, Zoom Communications (NASDAQ:ZM) discussed first-quarter financial ...
05-26 17:51
Seer Board Rejects Revised Radoff-JEC Acquisition Proposal
Seer ( ($SEER) ) has provided an announcement. On May 21, 2026, Seer, Inc. anno...
05-22 20:28
Seer rejects revised buyout proposal from Radoff-JEC Group
Seer (NASDAQ: SEER) on Thursday said its board unanimously rejected a revised unsolicited proposal from the Radoff-JEC Group to acquire all outstanding Class A common shares for $2.40 per share in cas...
05-22 04:50
Seer Rejects Proposed $2.40/Share Acquisition Offer From Bradley L. Radoff And Michael Torok
Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the "Board") has thoroughly reviewed and unanimously rejected the further
05-22 04:40
